× |
|
Changes in Antidepressant Metabolism and Dosing Across Pregnancy and Early Postpartum PDF |
$40.00 |
|
$40.00 |
× |
|
Psilocybin and the Development of Serotonin Toxicity PDF |
$40.00 |
|
$40.00 |
× |
|
Mood Alterations During Interferon-Alfa Therapy in Patients With Chronic Hepatitis C: Evidence for an Overlap Between Manic/Hypomanic and Depressive Symptoms PDF |
$40.00 |
|
$40.00 |
× |
|
Becoming PDF |
$40.00 |
|
$40.00 |
× |
|
Electroconvulsive Therapy Is Helpful for Patients With Obsessive-Compulsive Disorder-Related Disorders: A Response to dos Santos-Ribeiro et al PDF |
$40.00 |
|
$40.00 |
× |
|
Injectable Risperidone During Hemodialysis PDF |
$40.00 |
|
$40.00 |
× |
|
Real-Life Dosing With Second-Generation Antipsychotics PDF |
$40.00 |
|
$40.00 |
× |
|
The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population PDF |
$40.00 |
|
$40.00 |
× |
|
What's Next After 50 Years of Psychiatric Drug Development: An FDA Perspective PDF |
$40.00 |
|
$40.00 |
× |
|
Androgen Deficiency: Association With Increased Anxiety and Depression Symptom Severity in Anorexia Nervosa PDF |
$40.00 |
|
$40.00 |
× |
|
Controlled Double-Blind Trial of Phenytoin vs. Fluoxetine in Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia. PDF |
$40.00 |
|
$40.00 |
× |
|
Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia PDF |
$40.00 |
|
$40.00 |
× |
|
Neuropsychiatric Manifestations of Autoimmune Encephalitis in a Tertiary Hospital: A Case Series and Current Perspectives PDF |
$40.00 |
|
$40.00 |
× |
|
Vaptans for Hyponatremia Induced by Psychogenic Polydipsia PDF |
$40.00 |
|
$40.00 |
|